Cholesterol lowering in the elderly population

Scott M Grundy; James I. Cleeman; Basil M. Rifkind; Lewis H. Kuller

doi:10.1001/archinte.159.15.1670

Cholesterol lowering in the elderly population

Scott M Grundy, James I. Cleeman, Basil M. Rifkind, Lewis H. Kuller

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Abstract

The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.

Original language	English (US)
Pages (from-to)	1670-1678
Number of pages	9
Journal	Archives of Internal Medicine
Volume	159
Issue number	15
DOIs	https://doi.org/10.1001/archinte.159.15.1670
State	Published - Aug 9 1999

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/archinte.159.15.1670

Cite this

@article{d3c9bc0e28be48c8bd8b828c5194478f,

title = "Cholesterol lowering in the elderly population",

abstract = "The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.",

author = "Grundy, {Scott M} and Cleeman, {James I.} and Rifkind, {Basil M.} and Kuller, {Lewis H.}",

year = "1999",

month = aug,

day = "9",

doi = "10.1001/archinte.159.15.1670",

language = "English (US)",

volume = "159",

pages = "1670--1678",

journal = "Archives of Internal Medicine",

issn = "0003-9926",

publisher = "American Medical Association",

number = "15",

}

TY - JOUR

T1 - Cholesterol lowering in the elderly population

AU - Grundy, Scott M

AU - Cleeman, James I.

AU - Rifkind, Basil M.

AU - Kuller, Lewis H.

PY - 1999/8/9

Y1 - 1999/8/9

N2 - The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.

AB - The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.

UR - http://www.scopus.com/inward/record.url?scp=0033598081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033598081&partnerID=8YFLogxK

U2 - 10.1001/archinte.159.15.1670

DO - 10.1001/archinte.159.15.1670

M3 - Article

C2 - 10448768

AN - SCOPUS:0033598081

SN - 0003-9926

VL - 159

SP - 1670

EP - 1678

JO - Archives of Internal Medicine

JF - Archives of Internal Medicine

IS - 15

ER -

Cholesterol lowering in the elderly population

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this